We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock

Delisted

FRTX was delisted on the 18th of December, 2023.

43 hedge funds and large institutions have $10.5M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

5% more funds holding

Funds holding: 4143 (+2)

10% less capital invested

Capital invested by funds: $11.6M → $10.5M (-$1.12M)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
43
Holders Change
+2
Holders Change %
+4.88%
% of All Funds
1.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
8
Closed
3
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$26K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.89M -$112K -97 -3%
AI
2
Ariel Investments
Illinois
$2.17M -$518K -449 -20%
BIT
3
BlackRock Institutional Trust
California
$1.19M
Vanguard Group
4
Vanguard Group
Pennsylvania
$925K +$6.92K +6 +0.8%
Renaissance Technologies
5
Renaissance Technologies
New York
$811K +$174K +151 +30%
New York State Common Retirement Fund
6
New York State Common Retirement Fund
New York
$278K
Jacobs Levy Equity Management
7
Jacobs Levy Equity Management
New Jersey
$185K -$38.1K -33 -18%
Deutsche Bank
8
Deutsche Bank
Germany
$176K
SAIG
9
Semper Augustus Investments Group
Colorado
$145K -$1.15K -1 -0.8%
California Public Employees Retirement System
10
California Public Employees Retirement System
California
$120K
CCM
11
Condor Capital Management
New Jersey
$105K +$98K +85 New
Northern Trust
12
Northern Trust
Illinois
$50K
Connor, Clark & Lunn Investment Management (CC&L)
13
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$46K
Goldman Sachs
14
Goldman Sachs
New York
$46K +$5.77K +5 +16%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$40K
Two Sigma Advisers
16
Two Sigma Advisers
New York
$39K
Citigroup
17
Citigroup
New York
$28K +$3.46K +3 +15%
SIM
18
Spark Investment Management
New York
$25K -$55.4K -48 -70%
EAM
19
Evanson Asset Management
California
$25K
CCM
20
Coldstream Capital Management
Washington
$20K +$18.4K +16 New
RFC
21
Russell Frank Company
Washington
$17K
Citadel Advisors
22
Citadel Advisors
Florida
$17K +$16.1K +14 New
BMM
23
Berkshire Money Management
Massachusetts
$15K
Charles Schwab
24
Charles Schwab
California
$14K
State Street
25
State Street
Massachusetts
$14K

FRTX Hedge Fund Activity: Q1 2016 in Review

43 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2016, worth a combined $10.5M — down 9.6% from $11.6M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new FRTX positions and 3 closed out — a net gain of 2 holders — while 6 added to existing stakes and 8 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $174K. The largest seller was Ariel Investments, cutting an estimated $518K.

  • 43 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2016, up from 41 in Q4 2015.
  • Funds reported $10.5M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2016, down 9.6% quarter-over-quarter.
  • 5 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2016 and 3 closed out, a net change of +2 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2016 was Renaissance Technologies, an estimated $174K added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2016 was Ariel Investments, an estimated $518K sold.

Based on aggregated 13F filings for Q1 2016.